The Organ Trail
A Modern Journey to Save Lives
If you think organ transplants are a triumph of modern medicine, you’re right—but they’re also a logistical nightmare. Picture a kidney setting out on The Organ Trail—not unlike the Oregon Trail, but with higher stakes and fewer oxen. Instead of dysentery, the danger is time itself. If that kidney doesn’t reach its destination in time, it’s game over.
This is a problem. And solving it isn’t just about speed—it’s about ingenuity. So I’m setting off on a journey to explore the technologies, companies, and people working to slow time, bend biology, and reimagine what it means to move, store, and even create organs.
To break it down, I’ve mapped the problem space into seven categories. Each of these captures a piece of the puzzle, and together, they’re shaping a future where organ shortages could be a relic of the past.
Here’s a quick tour..
1. Hypothermic Machine Perfusion
Keeping organs cold to slow metabolism and extend their usability. Think of it as hitting "pause" while they wait for surgery. Companies like XVIVO Perfusion and Bridge to Life are working on improvements here.
2. Normothermic Machine Perfusion
Keeping organs alive and functioning outside the body allows for real-time monitoring, assessment, and even repair, significantly increasing the number of transplantable organs. TransMedics’ Organ Care System is an example of this approach.
3. Portable Organ Transport
Organs need special care on the move. Companies are working on systems that monitor and stabilize organs during long trips, ensuring they arrive in perfect condition.
4. Cryopreservation and Long-Term Organ Storage
Subzero preservation is pushing boundaries in organ storage. X-Therma is extending viability for transplants with short-term subzero transport, while Cradle is focused on reversible whole organ cryopreservation, aiming for true organ banking in the future.
5. Bioengineering and Regenerative Medicine
If the supply can’t meet the demand, why not grow new organs? United Therapeutics is printing lungs and LyGenesis is working on regrowing organs inside the body.
6. Immunomodulation and Transplant Tolerance
Even the perfect organ match can be rejected by the immune system. Quell Therapeutics and Sangamo Therapeutics are working on therapies to reprogram the body to accept transplants without heavy drugs.
7. Xenotransplantation and Genetic Engineering
Companies like eGenesis and Revivicor are editing animal organs to be compatible with humans, opening the door to a whole new donor supply.
In the months ahead, I’ll be diving deep into each of these areas.
Let’s see where the trail leads!